[1]
Saboor, F. and Lu, J. 2026. Conversion and Neoadjuvant Therapy for Intrahepatic Cholangiocarcinoma: Integrating Precision Medicine to Redefine Surgical Curability. Journal of Gastrointestinal and Liver Diseases. 35, 3 (Jul. 2026), 469–481. DOI:https://doi.org/10.15403/jgld-6761.